JorgeAlbertoMarreroMDMS

Gastroenterology • Philadelphia, PA

Hepatology & Liver Transplantation

Professor, Internal Medicine, University of Pennsylvania Perelman School of Medicine

Join to view full profile

Dr. Marrero is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Marrero's full profile

Already have an account?

Office
3400 Civic Center Blvd
PCAM South Pavilion 713
Philadelphia, PA 19104
Phone+1 215-614-1929

Education & Training

The University of Texas at DallasMS, Master of Science in Healthcare Leadership and Management, 2015 - 2017
University of MichiganMS, Clinical Research Design and Statistical Analysis, 2001 - 2003
University of Illinois College of Medicine at ChicagoFellowship, Gastroenterology, 1996 - 1999
Drexel University College of Medicine/Hahnemann University HospitalResidency, Internal Medicine, 1993 - 1996
Ponce Health Sciences University School of MedicineClass of 1993

Certifications & Licensure

PA State Medical License 1995 - 2024
TX State Medical License 2012 - 2021
MI State Medical License 2000 - 2013
IL State Medical License 1996 - 2002
American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Publications & Presentations

PubMed

Phase 3 Validation of Prognostic Liver Secretome Signature With α-Fetoprotein Plus Age, Male Sex, Albumin-Bilirubin, and Platelets for Hepatocellular Carcinoma Risk St...
Naoto Fujiwara, Camden Lopez, Tracey L Marsh, Indu Raman, Cesia A Marquez
Gastroenterology. 2024-11-08
National Liver Cancer Screening Trial (TRACER) study protocol.
Amit G Singal, Neehar D Parikh, Fasiha Kanwal, Jorge A Marrero, Sneha Deodhar
Hepatology Communications. 2024-11-01
Serum levels of total bile acids are associated with an increased risk of HCC in patients with cirrhosis.
Hashem B El-Serag, Aaron P Thrift, Hao Duong, Jing Ning, Saira Khaderi
Hepatology Communications. 2024-11-01

Press Mentions

An Unprecedented Year Sees Unprecedented Expansion in Physician Leadership at Penn MedicineDecember 16th, 2021